Európska únia - lotyština - EMA (European Medicines Agency)

vmd n.v. - tulatromicīns - antibacterials for systemic use, macrolides - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. slimības klātbūtne ganāmpulkā jānosaka pirms metapigaktiskas apstrādes. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. slimības klātbūtne ganāmpulkā jānosaka pirms metapigaktiskas apstrādes. the product should only be used if pigs are expected to develop the disease within 2–3 days. aitas: Ārstēšana agrīnā stadijā infekcijas pododermatitis (pamatnes puve), kas saistīts ar bīstamu dichelobacter nodosus nepieciešama sistēmiska ārstēšana.

Európska únia - lotyština - EMA (European Medicines Agency)

astrazeneca ab - acalabrutinib - leikēmija, limfocītu, hroniska, b-šūna - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

Európska únia - lotyština - EMA (European Medicines Agency)

accord healthcare s.l.u. - cabazitaxel - prostatas audzējiem, kastrācija-izturīgs - antineoplastiski līdzekļi - treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.

Európska únia - lotyština - EMA (European Medicines Agency)

dechra regulatory b.v. - tulatromicīns - antibakteriālie līdzekļi sistēmiskai lietošanai - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. slimības klātbūtne ganāmpulkā jānosaka pirms metapigaktiskas apstrādes. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. slimības klātbūtne ganāmpulkā jānosaka pirms metapigaktiskas apstrādes. the product should only be used if pigs are expected to develop the disease within 2–3 days. aitas: Ārstēšana agrīnā stadijā infekcijas pododermatitis (pamatnes puve), kas saistīts ar bīstamu dichelobacter nodosus nepieciešama sistēmiska ārstēšana.

Európska únia - lotyština - EMA (European Medicines Agency)

accord healthcare s.l.u. - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Európska únia - lotyština - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - kaķi - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. veterinārās zāles ir tikai norādīts, kad visas trīs grupas ir mērķtiecīgi, tajā pašā laikā.

Európska únia - lotyština - EMA (European Medicines Agency)

novartis ireland ltd - ofatumumabs - multiplā skleroze, recidivējoši-pārskaitot - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

Európska únia - lotyština - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - azacitidine - leikēmija, mieloīds, akūts - antineoplastiski līdzekļi - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

Európska únia - lotyština - EMA (European Medicines Agency)

estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - dzimumhormoni un dzimumsistēmas modulatori dzimumorgānu sistēma, - mutes trakta kontracepcija. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.

Európska únia - lotyština - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - antineoplastiski līdzekļi - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).